• Home
  • COVID-19 and immune checkpoint inhibitors: initial considerations.

COVID-19 and immune checkpoint inhibitors: initial considerations.

Author List
Sullivan RJ, Johnson DB, Rini BI, Neilan TG, Lovly CM, Moslehi JJ, Reynolds KL
Publication
Journal for immunotherapy of cancer
Publication ID (Profile URL)
https://researcherprofiles.org/profile/234265214
Publication Year
2020
PubMed ID
32434790
Publication Title
Sullivan RJ, Johnson DB, Rini BI, Neilan TG, Lovly CM, Moslehi JJ, Reynolds KL. COVID-19 and immune checkpoint inhibitors: initial considerations. J Immunother Cancer. 2020 05; 8(1).